Doctors in England have issued warnings regarding the risks posed to children with ADHD by poorly regulated private clinics that often prescribe powerful stimulant medications without proper physical examinations. This alarming trend has arisen in part due to a surge in remote assessments, where clinicians diagnose and prescribe treatments during virtual consultations. As a result, many children are being treated without thorough evaluations that could identify underlying health conditions, particularly heart issues, before administering these medications.

In response to these concerns, health authorities in Greater Manchester are taking action by reevaluating their prescribing protocols to ensure the safety of pediatric patients. The new guidelines will mandate face-to-face assessments for children diagnosed with ADHD prior to receiving prescriptions. This initiative aims to curb the practice of prescribing medications based solely on remote evaluations, which has been deemed unsafe by experts in the field.

Rashad Nawaz, a consultant pediatrician, has been vocal about the issue by addressing national regulators and health entities regarding the alarming frequency of inappropriate prescriptions. The use of stimulants like methylphenidate (known commonly as Ritalin) requires careful consideration of a child's physical health, and the ongoing reports from practitioners indicate an urgent need for improved regulatory oversight to protect vulnerable young patients from potential harm.